Five protease inhibitors with different modes of action were found to reduce the growth of transformed mouse (Py3T3, SV3T3, and 3T12) and hamster (PyBHK) cells. Some of these inhibitors caused the transformed cells to cease growth at saturation densities characteristic for nontransformed cells.
Normal cells in tissue culture cease to divide upon formation of a monolayer. This phenomenon, which has been termed contact inhibition (1) or density-dependent inhibition of growth (2) , is observed to a much lesser degree in virally or spontaneously transformed cells.
Proteolytic treatment temporarily releases normal fibroblasts from contact inhibition (3, 4) , and induces the appearance of surface properties characteristic of transformed cells (5) (6) (7) (8) (9) . This finding implies the existence of a proteolytic activity in transformed cells that might be responsible for some of the cell surface alterations associated with the release from contact inhibition of growth (5, 10) . If this speculation were correct, inhibition of this proteolytic activity should lead to a decreased growth of transformed cells and, possibly, to an "induction" of contact inhibition.
This report describes the strikingly selective inhibition of growth of transformed cells by five commercially available protease inhibitors, and suggests that these cells require a protease-like activity for escape from contact inhibition. The following protease inhibitors were used: Tosyl-arginine methylester (TAME), Tosyl-phenylalanyl-chloromethylketone (TPCK) and Tosyl-lysyl-chloromethylketone (TLCK) all from Calbiochem; soybean trypsin inhibitor 1-S (Sigma), ovomucoid II 0 (Sigma), and Trasylol injectible (5000 units/ml) from Bayer. Trasylol was dialyzed against phosphate-buffered saline, pH 7.4 to remove a toxic bactericidal additive before use.
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RESULTS AND DISCUSSION
As an example of the cell growth curves obtained in the presence or absence of protease inhibitors, the effect of TLCK on the proliferation of SV3T3 and 3T3 cells is shown in Fig. 1 Fig. 1, left) . The cells were trypsinized and used for dye exclusion and plating efficiency tests. For plating efficiency tests, 100 cells were plated in normal medium in a 6-cm dish, and colonies were counted after 7 days (means of four independent determinations). and the plateau (saturation density) of this curve resemble those of 3T3 growth curves. Microscopic examination revealed that the TLCK-treated transformed cells were much flatter than the untreated cells, but that they still overlapped and grew in irregular patterns.
The growth of the 3T3 cells was unaffected at concentrations up to 50 /Ag/ml of TLCK (Fig. 1, right) . At higher concentrations (above 200 yg/ml) growth of untransformed cells begins to be affected also; the cells round up and show signs of general toxicity.
At 50 /g/ml (the concentration producing severe inhibition of SV3T3 cells; Fig. 1, left) , TLCK is not toxic as judged by dye exclusion and plating efficiency tests (Table 1) . TLCK acts on the cells directly and does not affect growth by interacting with serum components of the medium (Table 2) : TLCK-treated, dialyzed serum supported growth as well as did the untreated serum. Furthermore, transformed cells treated with TLCK for 1 hr, then washed and grown in control medium, remained inhibited for 24 hr (Table 2) .
With most of the other inhibitors, solubility problems limited the range of concentrations tested. The inhibitions thus obtained were less dramatic, and the curves typically resembled that of the partially inhibited SV3T3 culture (25 Atg/ml) in Fig. 1 , left. 48 hr before the experiment; media were changed at the beginning and every 24 hr during the experiment. Cells were counted 72 hr after the first medium change. All media contained 10% fetal-calf serum; where noted, the serum was dialyzed extensively against phosphate-buffered saline (pH 7.4) or treated with 1 mg/ml of TLCK for 1 hr at 370 before exhaustive dialysis. In the last experiment the cells were exposed to TLCK (100 ,ug/ml) for only 1 hr at the beginning of each day of the experiment; after this exposure, the cells were washed twice and grown in control medium. The effects of six protease inhibitors on the growth of 3T3, Py3T3, SV3T3, and 3T12 cells are summarized in Fig. 2 . Transformed cells were inhibited in a dose-dependent manner by all inhibitors, except for the soybean trypsin inhibitor. In contrast, growth of 3T3 cells was not impaired by any of these compounds. TLCK, TPCK, and ovomucoid similarly inhibited the growth of PyBHK cells without affecting the growth of the parental BHK-cells (not shown).
The inhibitors used are of different types: TAME is a substrate analogue and acts competitively on proteases and esterases (11) ; TLCK and TPCK are "active-site titrants," reacting irreversibly with the enzyme (12); and ovomucoid forms a poorly dissociating macromolecular complex with proteases of the trypsin family (13) . Since it is improbable that inhibitors with such different mechanisms of action would all have similar side effects, it is likely that the inhibition of growth observed in this study is, in fact, due to the inhibition of a protease.
Transformed cells could hydrolyze Chlorella [14C]protein more efficiently than their normal counterparts under conditions where phagocytosis was negligible (14) . In fact, transformed cells, when brought into contact with stationary 3T3 cells, were able to remove surface material from the stationary cells (14) and caused overgrowth analogous to a trypsin treatment (15) . This result suggested that transformed cells contain more of a protease-like activity on their surface than do normal cells.
Ovomucoid covalently linked to Sepharose beads is effective in inhibiting growth of transformed cells, as is soluble ovomucoid (M. M. Burger, unpublished) , again indicating that the-target of the protease inhibitors might be pericellular.
It is concluded that an inhibitor-sensitive, protease-like activity, which appears to be surface located, is required by the transformed cells for unrestrained growth. If contact inhibition depends on intercellular interactions through specific receptor structures, one is tempted to speculate (although there is no evidence for this) that the protease-like Proc. Nat. Acad. Sci. USA 69 (1972) dl' 6-activity destroys or modifies surface structures involved in normal cell-to-cell contacts.
Indeed, TLCK treatment of Py3T3 cells (50 jsg/ml, 96 hr) renders these cells less agglutinable with wheat-germ agglutinin (5-fold) and with concanavalin A (3-fold), indicating that this inhibitor prevents some of the surface modifications characteristic of transformed cells.
In the context of the present experiments, it is interesting that TAME, TLCK, and TPCK have successfully been used to suppress dimethylbenzanthracene-induced and phorbolester-promoted tumorigenesis in mouse skin (16) . This finding is compatible with the suggestion above that a protease-like activity is required for the malignant expression of a cell.
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